nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—Parkinson's disease	0.917	1	CbGaD
Carteolol—Bopindolol—HTR1A—Parkinson's disease	0.00191	0.233	CrCbGaD
Carteolol—Penbutolol—HTR1A—Parkinson's disease	0.00182	0.223	CrCbGaD
Carteolol—Pindolol—HTR1A—Parkinson's disease	0.00131	0.161	CrCbGaD
Carteolol—Nadolol—ABCB1—Parkinson's disease	0.000895	0.109	CrCbGaD
Carteolol—Pindolol—CYP2D6—Parkinson's disease	0.000788	0.0963	CrCbGaD
Carteolol—Propranolol—HTR1A—Parkinson's disease	0.000717	0.0876	CrCbGaD
Carteolol—Propranolol—CYP2D6—Parkinson's disease	0.00043	0.0525	CrCbGaD
Carteolol—ADRB2—G alpha (s) signalling events—DRD1—Parkinson's disease	0.000414	0.00553	CbGpPWpGaD
Carteolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000404	0.0054	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—GPR37—Parkinson's disease	0.000394	0.00526	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—GPR37—Parkinson's disease	0.000385	0.00515	CbGpPWpGaD
Carteolol—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000378	0.00505	CbGpPWpGaD
Carteolol—ADRB1—G alpha (s) signalling events—HTR7—Parkinson's disease	0.000371	0.00495	CbGpPWpGaD
Carteolol—ADRB2—G alpha (s) signalling events—HTR7—Parkinson's disease	0.000363	0.00485	CbGpPWpGaD
Carteolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000339	0.00453	CbGpPWpGaD
Carteolol—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000335	0.00447	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000333	0.00445	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000326	0.00435	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Other—HTR2A—Parkinson's disease	0.000325	0.00435	CbGpPWpGaD
Carteolol—Propranolol—ABCB1—Parkinson's disease	0.000307	0.0375	CrCbGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000305	0.00407	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000298	0.00398	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000281	0.00376	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000275	0.00367	CbGpPWpGaD
Carteolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000275	0.00367	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—GRM4—Parkinson's disease	0.000268	0.00358	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—GRM4—Parkinson's disease	0.000262	0.0035	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—PENK—Parkinson's disease	0.000254	0.00339	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—PENK—Parkinson's disease	0.000248	0.00332	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000244	0.00326	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000241	0.00322	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000241	0.00322	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000239	0.00319	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000238	0.00318	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000236	0.00315	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000236	0.00315	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—PDYN—Parkinson's disease	0.000232	0.0031	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00023	0.00308	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000228	0.00305	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—PDYN—Parkinson's disease	0.000227	0.00303	CbGpPWpGaD
Carteolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000226	0.00302	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000223	0.00298	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000222	0.00297	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000218	0.00291	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—GRM5—Parkinson's disease	0.000216	0.00288	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000215	0.00287	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—GRM5—Parkinson's disease	0.000211	0.00282	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000209	0.00279	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000206	0.00276	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000206	0.00276	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000206	0.00275	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000204	0.00273	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GPR37—Parkinson's disease	0.000202	0.0027	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000202	0.0027	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000202	0.0027	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000202	0.0027	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000202	0.0027	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000201	0.00269	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.000198	0.00264	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000198	0.00264	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000197	0.00264	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000195	0.00261	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000191	0.00256	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000185	0.00247	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000183	0.00245	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000181	0.00242	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000179	0.0024	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000177	0.00236	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000177	0.00236	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000173	0.00231	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000173	0.00231	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000169	0.00225	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000165	0.0022	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000159	0.00213	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.000157	0.00209	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000156	0.00208	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.000154	0.00205	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.000153	0.00205	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.000153	0.00205	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000151	0.00202	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.00015	0.00201	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.00015	0.002	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.000149	0.00199	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000148	0.00198	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000146	0.00195	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.000146	0.00195	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000145	0.00193	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.000144	0.00192	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000144	0.00192	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.000143	0.00192	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000142	0.00189	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000141	0.00189	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.000141	0.00188	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.00014	0.00187	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000138	0.00185	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.000137	0.00184	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.000135	0.0018	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.000135	0.0018	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.000134	0.0018	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.000132	0.00176	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.000132	0.00176	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000131	0.00175	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.00013	0.00174	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000128	0.00171	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.000127	0.0017	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000124	0.00165	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000122	0.00163	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000121	0.00162	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000121	0.00162	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.00012	0.00161	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.00012	0.00161	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000119	0.00159	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000119	0.00159	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000119	0.00159	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000119	0.00159	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000119	0.00159	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000119	0.00159	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.000117	0.00156	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.000117	0.00156	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.000116	0.00156	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000111	0.00148	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000111	0.00148	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000109	0.00146	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000109	0.00146	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000108	0.00145	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.000108	0.00144	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000107	0.00143	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000105	0.00141	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000104	0.00139	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000101	0.00135	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	9.54e-05	0.00127	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	9.43e-05	0.00126	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	9.41e-05	0.00126	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	9.33e-05	0.00125	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	9.22e-05	0.00123	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	9.21e-05	0.00123	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	9.04e-05	0.00121	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	8.99e-05	0.0012	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	8.86e-05	0.00118	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	8.85e-05	0.00118	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	8.8e-05	0.00118	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	8.69e-05	0.00116	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	8.66e-05	0.00116	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	8.5e-05	0.00114	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	8.41e-05	0.00112	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	8.23e-05	0.0011	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	8.17e-05	0.00109	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	8.11e-05	0.00108	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	8.04e-05	0.00107	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	7.99e-05	0.00107	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	7.94e-05	0.00106	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	7.89e-05	0.00105	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	7.87e-05	0.00105	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.86e-05	0.00105	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	7.84e-05	0.00105	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ND3—Parkinson's disease	7.84e-05	0.00105	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	7.72e-05	0.00103	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	7.69e-05	0.00103	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	7.69e-05	0.00103	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.68e-05	0.00103	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	7.64e-05	0.00102	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	7.61e-05	0.00102	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	7.61e-05	0.00102	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	7.52e-05	0.00101	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	7.52e-05	0.00101	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	7.47e-05	0.000999	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	7.44e-05	0.000994	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	7.44e-05	0.000994	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.38e-05	0.000986	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—OMD—Parkinson's disease	7.38e-05	0.000986	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.13e-05	0.000953	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	7.03e-05	0.00094	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	6.99e-05	0.000934	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	6.98e-05	0.000932	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	6.91e-05	0.000923	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	6.91e-05	0.000923	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	6.88e-05	0.000919	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	6.76e-05	0.000903	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	6.76e-05	0.000903	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.67e-05	0.000891	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	6.61e-05	0.000884	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	6.54e-05	0.000874	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	6.47e-05	0.000864	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	6.4e-05	0.000855	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	6.09e-05	0.000814	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	5.96e-05	0.000796	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	5.95e-05	0.000794	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DBH—Parkinson's disease	5.95e-05	0.000794	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GBA—Parkinson's disease	5.95e-05	0.000794	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	5.73e-05	0.000766	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	5.61e-05	0.00075	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	5.56e-05	0.000743	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	5.53e-05	0.000739	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	5.44e-05	0.000727	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	5.41e-05	0.000723	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.33e-05	0.000712	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.21e-05	0.000696	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	5.13e-05	0.000686	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	5.02e-05	0.000671	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	4.85e-05	0.000648	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	4.84e-05	0.000647	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	4.82e-05	0.000645	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	4.75e-05	0.000635	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	4.74e-05	0.000634	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	4.73e-05	0.000632	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	4.72e-05	0.000631	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	4.66e-05	0.000623	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	4.65e-05	0.000621	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	4.56e-05	0.000609	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.51e-05	0.000603	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	4.41e-05	0.00059	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DDC—Parkinson's disease	4.36e-05	0.000583	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.21e-05	0.000563	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	4.12e-05	0.000551	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.12e-05	0.000551	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.08e-05	0.000545	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.08e-05	0.000545	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	3.99e-05	0.000533	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	3.99e-05	0.000533	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.71e-05	0.000496	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.67e-05	0.000491	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.42e-05	0.000457	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	3.35e-05	0.000447	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.31e-05	0.000442	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.27e-05	0.000437	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	3.23e-05	0.000432	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	3.2e-05	0.000427	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3e-05	0.000401	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	2.94e-05	0.000392	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.86e-05	0.000382	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	2.8e-05	0.000374	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.68e-05	0.000358	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.66e-05	0.000355	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.6e-05	0.000347	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.5e-05	0.000334	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.47e-05	0.00033	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TH—Parkinson's disease	2.43e-05	0.000325	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.34e-05	0.000312	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.27e-05	0.000303	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	2.22e-05	0.000297	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—COMT—Parkinson's disease	2.07e-05	0.000276	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.06e-05	0.000275	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.05e-05	0.000275	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.03e-05	0.000271	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.95e-05	0.00026	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.89e-05	0.000253	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.81e-05	0.000242	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.69e-05	0.000226	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.68e-05	0.000224	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.67e-05	0.000223	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.65e-05	0.000221	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.64e-05	0.000219	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.56e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.55e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.52e-05	0.000203	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—INS—Parkinson's disease	1.33e-05	0.000178	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	9.92e-06	0.000133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	9.7e-06	0.00013	CbGpPWpGaD
